Internal Medicine
AGH General Surgery Residency Program

AGH General Residency Program Home
About the Program
About the Region
Why AGH?

Find Out More...
Surgery Residents
Our Graduates
Faculty
Director's Statement
Message from the President
Residency Program Goals and Objectives
Core Curriculum
Surgical Subspecialties
Conferences
Stipends and Benefits
Research
Resident Resources
Application Information
Appointment Contract
Hotel Information
Links to Pittsburgh Information
Contact Information

Colon and Rectal Surgery Fellowship

Bariatric Surgery Fellowship

Susan G. Komen Interdisciplinary Breast Fellowship

Vascular Surgery Fellowship Program



Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.

Medich D. McGinty J. Parda D. Karlovits S. Davis C. Caushaj P. Lembersky B.

West Penn Allegheny Health System, Pittsburgh, PA 15212, USA.

Diseases of the Colon & Rectum. 44(8):1123-8, 2001 Aug.

Abstract

PURPOSE: Preoperative chemoradiotherapy followed by radical surgical resection has been the preferred treatment for patients presenting with locally advanced distal rectal carcinoma at our institutions. We postulated that chemoradiotherapy-induced pathologic response of the primary tumor would identify which patients would be candidates for local excision as definitive surgical therapy.

METHODS: A retrospective analysis of 60 patients with palpable, locally advanced, distal rectal adenocarcinomas treated from 1995 to 2000 was performed. All patients received preoperative chemoradiotherapy consisting of 5-fluorouracil (325 mg/m(2)) and leucovorin (20 mg/m(2)) by bolus infusion on Days 1 through 5 and 29 through 33 delivered concurrently with at least 45.0 to 50.4 Gy of pelvic radiation, followed six to eight weeks later by radical surgery and then adjuvant chemotherapy.

RESULTS: Among 60 patients (20 females) there was a mean age of 58.7 (28-84) years. Clinical staging was as follows: Stage II, 14 patients (23 percent); Stage III, 35 patients (58 percent); and Stage IV, 11 patients (18 percent). Pathologic examination revealed that negative margins were obtained in 58 patients (97 percent). Downstaging to T0-2N0 was achieved in 17 patients (28 percent), with five (8 percent) achieving a pathologically complete response. Lymph nodes were positive in 24 patients (40 percent) despite chemoradiotherapy. Pathologic node positivity was found in 0 of 5 pT0 patients, 9 (41 percent) of 22 pT1 or pT2, and 15 (45 percent) of 33 pT3. Clinical stage, tumor size, pathologic stage, and adverse histologic features could not reliably predict pN0 status, except pT0 (5 patients only).

CONCLUSIONS: Preoperative chemoradiotherapy often downsizes and downstages locally advanced rectal carcinoma. Neither pretreatment clinical characteristics, response to preoperative chemoradiotherapy, or pathologic features reliably predict pN0 status. Therefore, local excision is not recommended as an alternative to radical surgery for locally advanced adenocarcinoma of the distal rectum regardless of the response of the primary tumor to preoperative chemoradiotherapy.



> Back



AGH General Surgery Residency Program Home | Disclaimer | Contact Webmaster

© West Penn Allegheny Health System. All rights reserved.